Browse > Article

Screening of Chinese Herbal Medicines with Inhibitory Effect on Aldose Reductase (III)  

Lee, Yun-Mi (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Kim, Jong-Min (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Kim, Young-Sook (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Jang, Dae-Sik (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Kim, Joo-Hwan (Department of Life Science, Kyungwon University)
Bae, Ki-Hwan (College of Pharmacy, Chungnam National University)
Kim, Jin-Sook (Diabetic Complications Research Center, Division of Traditional Korean Medicine (TKM) Integrated Research, Korea Institute of Oriental Medicine)
Publication Information
Korean Journal of Pharmacognosy / v.40, no.4, 2009 , pp. 394-399 More about this Journal
Abstract
Aldose reductase (AR) is a critical enzyme in the development of the diabetic complications. AR, the first enzyme in the polyol pathway, catalyzes the reduction of the aldehyde form of glucose to sorbitol with concomitant conversion of NADPH to $NADP^+$. None of aldose reductase inhibitor (ARI) has achieved worldwide use because of limited efficacy or undesirable side effects. Therefore, evaluating natural sources for ARI potential may lead to the development of safer and more effective agents against diabetic complications. Forty eight Chinese herbal medicines have been investigated for inhibitory activities on AR. Among them, seven herbal medicines, Buddleja officinalis (whole plant), Lonicera japonica (leaf and flower), Polygonum aviculare (aerial part), Polygonum aviculare (whole plant), Salvia miltiorrhiza (root), Schisandra chinensis (stem), and Zanthoxylum armatum (leaf and stem) exhibited a significant inhibitory activity against AR. Particularly, L. japonica and P. aviculare showed two times more potent inhibitory activity than the positive control, 3,3-tetramethyleneglutaric acid (TMG).
Keywords
Diabetic complications; Aldose reductase inhibitor; Chinese herbal medicines;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Maccari, R., Ottana, R., Curinga, C., Vigorita, M. G., Rakowitz, D., Steindl, T. and Langer, T. (2005) Structure-activity relationships and molecular modeling of 5-arylidene-2,4-thiazolidinediones active as aldosse reductase inhibitors. Bioorg. Med. Chem. 13: 2809-2823   DOI   ScienceOn
2 Hotta, N., Akanuma, Y., Kawamori, R., Matsuoka, K., Oka, Y., Shichiri, M., Toyota, T., Nakashima, M., Yoshimura, I., Sakamoto, N. and Shigeta, Y. (2006) Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy. Diabetes Care 29: 1538-1544   DOI   ScienceOn
3 Chalk, C., Benstead, T. J. and Moore, F. (2007) Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst. Rev. 4:CD004572
4 Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254   DOI   PUBMED   ScienceOn
5 Handelsman, D. J. and Turtle, J. R. (1981) Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes. 30: 459-464   DOI   ScienceOn
6 Hur, J. (1983) Tongeuibokam, 744. Namsadang, Seoul
7 Piao, M. S., Kim, M. R., Lee, D. G., Park, Y., Hahm, K. S., Moon, Y. H. and Woo, E. R. (2003) Antioxidative constituents from Buddleja officinalis. Arch. Pharm. Res. 26: 453–457   DOI   ScienceOn
8 Yin, M. H., Kang, D. G., Choi, D. H., Kwon, T. O. and Lee, H. S. (2005) Screening of vasorelaxant activity of some medicinal plants used in Oriental medicines. J. Ethnopharmacol. 99: 113-117   DOI   ScienceOn
9 Tiwary , M., Naik, S. N., Tewary, D. K., Mittal, P. K. and Yadav, S. (2007) Chemical composition and larvicidal activities of the essential oil of Zanthoxylum armatum DC (Rutaceae) against three mosquito vectors. J. Vector Borne Dis. 44: 198-204   PUBMED
10 Hsu, C. Y. (2006) Antioxidant activity of extract from Polygonum aviculare L. Biol. Res. 39: 281-288   DOI
11 Jeon, Y. H., Kil, J. H., Lim, S. M., Kim, M. H. and Kim, M. R. (2008) Analysis of antioxidative activity and antimutagenic effect of ethanol extract from Schizandra chinensis Baillon. J. East Asian Soc. Dietary Life 18: 746-752   과학기술학회마을   ScienceOn
12 Chan, P., Liu, I. M., Li, Y. X., Yu, W. J. and Cheng, J. T. (2009) Antihypertension induced by tanshinone IIA isolated from the roots of Salvia Miltiorrhiza. eCAM. 2009 Jun 19. [Epub ahead of print]   DOI   ScienceOn
13 Matsuda, H., Cai, H., Kubo, M., Tosa, H. and Iinuma, M. (1995) Study on anti-cataract drugs from natural sources. II. Effects of buddlejae flos on in vitro aldose reductase activity. Biol. Pharm. Bull. 18: 463-466   DOI   PUBMED   ScienceOn
14 Lee, Y. M., Kim, N. H., Kim, J. M., Kim, Y. S., Jang, D. S., Kim, J. H., Bae, K. H. and Kim, J. S. (2008) Screening of inhibitory effect on aldose reductase of Korean herbal medicines and preventive effect of Catalpa bignonioides against xylose-induced lens opacity (I). Kor. J. Pharmacogn. 39: 165-173   과학기술학회마을
15 Matsumoto, T., Ono, Y., Kurono, M., Kuromiya, A., Nakamura, K. and Bril, V. (2008) Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocindiabetic rats. J. Pharmacol. Sci. 107: 231-237   DOI   ScienceOn
16 Xu, Z., Yang, H., Zhou, M., Feng, Y. and Jia, W. (2009) Inhibitory effect of total lignan from Fructus Arctii on aldose reductase. Phytother Res. Apr 16. [Epub ahead of print]   DOI   ScienceOn
17 Lee, C. G., Kim, N. J., Hong, N. D. and Kwon, C. H. (1994) Anti - lipid peroxidation and liver protective effects of Polygonum aviculare L. Kor. J. Pharmacogn. 25: 59-69
18 Son, K. H., Kim, J. S., Kang, S. S., Kim, H. P. and Chang, H. W. (1994) Isolation of Flavonoids from Lonicera japonica. Kor. J. Pharmacogn. 25: 24-27   과학기술학회마을   ScienceOn
19 Kyseloa, A., Stefek, M. and Bauer, V. (2004) Pharmacological prevention of diabetic cataract. J. Diabetes Complicat. 18: 129-140   DOI   ScienceOn
20 Constantino, L., Rastelli, G., Vianello, P., Cignarella, G. and Barlocco, D. (1999) Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Medical Research Reviews 19: 3-23   DOI   ScienceOn
21 Fu, X., Tian, H., Sheng, Z. and Wang, D. (1992) Multiple organ injuries after abdominal high energy wounding in animals and the protective effect of antioxidants. Chin. Med. Sci. J. 7: 86-91   PUBMED
22 Greene, D. A., Lattimer, S. A., and Sima, A. F. (1987) Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complication. New. Eng. J. Med. 316: 599-606   DOI   ScienceOn
23 Dufrane, S. P., Malaisse, W. J. and Sener, A. (1984) A micromethod for the assay of aldose reductase, its application to pancreatic islets. Biochem. Med. 32: 99-105   DOI   ScienceOn
24 Kinoshita, J. H., Dvornik, D., Kraml, M. and Gabbay, K. H. (1968) The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens. Biochim. Biophys. Acta. 24: 472-475
25 Lee, Y. M., Kim, J. M., Kim, Y. S., Jang, D. S., Kim, J. H., Bae, K. H. and Kim, J. S. (2008) Screening of inhibitory effect on aldose reductase of Vietnam herbal medicines (II). Kor. J. Pharmacogn. 39: 324-329   과학기술학회마을   ScienceOn
26 Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C. and Lorenzi, M. (2006) A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes 55: 2757-2762   DOI   ScienceOn
27 Drel, V. R., Pacher, P., Ali, T. K., Shin, J., Julius, U., El- Remessy, A. B. and Obrosova, I. G. (2008) Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. Int. J. Mol. Med. 21: 667-676   PUBMED
28 Ziegler, D. (2004) Polyneuropathy in the diabetic patientupdate on pathogenesis and management. Nephrol. Dial. Transplant. 19: 2170-2175   DOI   ScienceOn
29 Guo, H., Koike, K., Li, W., Satou, T., Guo, D and Nikaido, T. (2004) Saponins from the flower buds of Buddleja officinalis. J. Nat. Prod. 67: 10-13   DOI   ScienceOn
30 David, R. T., Elizabeth, J. S. and Lara, T. D. (1994) Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol. Sci. 15: 293-297   DOI   ScienceOn
31 Ramirez, M. A. and Borja, N. L. (2008) Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy. 28: 646-655   DOI   ScienceOn
32 Feng, C. G., Zhang, L. X. and Liu, X. (2005) Progress in research of aldose reductase inhibitors in traditional medicinal herbs. Zhongguo Zhong Yao Za Zhi. 30: 1496-1500   PUBMED
33 Jeong, J. B. and Jeong, H. J. (2009) Schisandra Chinensis Inhibits oxidative DNA damage and lipid peroxidation via antioxidant activity. Korean J. Plant Res. 22: 195-202   과학기술학회마을   ScienceOn